News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
414,673 Results
Type
Article (22606)
Company Profile (157)
Press Release (391895)
Multimedia
Podcasts (114)
Webinars (17)
Section
Business (121448)
Career Advice (1027)
Deals (24080)
Drug Delivery (114)
Drug Development (55256)
Employer Resources (84)
FDA (9268)
Job Trends (9083)
News (214412)
Policy (19764)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (917)
Accelerated approval (23)
Adcomms (23)
Allergies (90)
Alliances (32617)
ALS (101)
Alzheimer's disease (927)
Antibody-drug conjugate (ADC) (233)
Approvals (9478)
Artificial intelligence (322)
Autoimmune disease (99)
Automation (20)
Bankruptcy (218)
Best Places to Work (6686)
BIOSECURE Act (14)
Biosimilars (178)
Biotechnology (73)
Bladder cancer (90)
Brain cancer (41)
Breast cancer (317)
Cancer (2708)
Cardiovascular disease (258)
Career advice (863)
Career pathing (25)
CAR-T (132)
CDC (17)
Celiac Disease (1)
Cell therapy (357)
Cervical cancer (12)
Clinical research (48495)
Collaboration (1142)
Company closure (1)
Compensation (439)
Complete response letters (55)
COVID-19 (1269)
CRISPR (60)
C-suite (601)
Cystic fibrosis (91)
Data (3832)
Decentralized trials (2)
Denatured (27)
Depression (91)
Diabetes (291)
Diagnostics (2864)
Digital health (21)
Diversity (10)
Diversity, equity & inclusion (25)
Drug discovery (189)
Drug pricing (202)
Drug shortages (33)
Duchenne muscular dystrophy (146)
Earnings (47041)
Editorial (49)
Employer branding (10)
Employer resources (83)
Events (60670)
Executive appointments (694)
FDA (11137)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (806)
Gene editing (105)
Generative AI (35)
Gene therapy (299)
GLP-1 (847)
Government (2272)
Grass and pollen (4)
Guidances (241)
Healthcare (7985)
HIV (33)
Huntington's disease (25)
IgA nephropathy (62)
Immunology and inflammation (177)
Immuno-oncology (41)
Indications (81)
Infectious disease (1428)
Inflammatory bowel disease (137)
Inflation Reduction Act (12)
Influenza (55)
Intellectual property (160)
Interviews (137)
IPO (10854)
IRA (54)
Job creations (2587)
Job search strategy (753)
JPM (53)
Kidney cancer (10)
Labor market (63)
Layoffs (349)
Leadership (29)
Legal (4801)
Liver cancer (37)
Longevity (9)
Lung cancer (378)
Lymphoma (231)
Machine learning (24)
Management (31)
Manufacturing (581)
MASH (120)
Medical device (4856)
Medtech (4870)
Mergers & acquisitions (14040)
Metabolic disorders (956)
Multiple sclerosis (110)
NASH (20)
Neurodegenerative disease (179)
Neuropsychiatric disorders (75)
Neuroscience (1750)
Neurotech (1)
NextGen: Class of 2026 (3180)
Non-profit (1191)
Now hiring (47)
Obesity (533)
Opinion (239)
Ovarian cancer (76)
Pain (161)
Pancreatic cancer (122)
Parkinson's disease (185)
Partnered (21)
Patents (333)
Patient recruitment (291)
Peanut (22)
People (38509)
Pharmaceutical (77)
Pharmacy benefit managers (33)
Phase 1 (15247)
Phase 2 (20749)
Phase 3 (16261)
Pipeline (3481)
Policy (239)
Postmarket research (1688)
Preclinical (5507)
Press Release (62)
Prostate cancer (151)
Psychedelics (30)
Radiopharmaceuticals (218)
Rare diseases (564)
Real estate (3711)
Recruiting (35)
Regulatory (15505)
Reports (30)
Research institute (995)
Resumes & cover letters (157)
Rett syndrome (6)
RNA editing (12)
RSV (50)
Schizophrenia (134)
Series A (141)
Series B (108)
Service/supplier (7)
Sickle cell disease (76)
Special edition (21)
Spinal muscular atrophy (120)
Sponsored (20)
Startups (2355)
State (2)
Stomach cancer (13)
Supply chain (81)
Tariffs (94)
The Weekly (85)
Vaccines (462)
Venture capital (70)
Weight loss (385)
Women's health (45)
Worklife (9)
Date
Today (95)
Last 7 days (341)
Last 30 days (1335)
Last 365 days (17920)
2026 (2230)
2025 (18151)
2024 (21113)
2023 (23792)
2022 (31747)
2021 (33896)
2020 (31857)
2019 (25071)
2018 (19353)
2017 (20486)
2016 (19117)
2015 (22580)
2014 (17420)
2013 (14734)
2012 (15842)
2011 (15944)
2010 (14683)
Location
Africa (461)
Alabama (44)
Alaska (3)
Arizona (141)
Arkansas (8)
Asia (29505)
Australia (4377)
California (5971)
Canada (2027)
China (814)
Colorado (237)
Connecticut (261)
Delaware (208)
Europe (61424)
Florida (1021)
Georgia (181)
Hawaii (2)
Idaho (22)
Illinois (507)
India (54)
Indiana (336)
Iowa (9)
Japan (369)
Kansas (91)
Kentucky (30)
Louisiana (9)
Maine (56)
Maryland (714)
Massachusetts (4568)
Michigan (144)
Minnesota (312)
Mississippi (6)
Missouri (55)
Montana (17)
Nebraska (16)
Nevada (67)
New Hampshire (29)
New Jersey (2190)
New Mexico (22)
New York (1673)
North Carolina (1043)
North Dakota (3)
Northern California (2806)
Ohio (159)
Oklahoma (9)
Oregon (27)
Pennsylvania (1274)
Puerto Rico (21)
Rhode Island (32)
South America (673)
South Carolina (19)
Southern California (2477)
Tennessee (95)
Texas (873)
United States (22527)
Utah (147)
Vermont (1)
Virginia (188)
Washington D.C. (62)
Washington State (468)
West Virginia (2)
Wisconsin (67)
Wyoming (2)
414,673 Results for "chugai pharma usa llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dexcel Pharma USA Acquires US Rights to Zubsolv®
January 8, 2026
·
1 min read
Artificial intelligence
Roche’s Chugai Breaks Into Aging via Potential $1B+ Deal With AI Outfit Gero
The partnership will give Chugai access to Gero’s artificial intelligence technology to discover novel targets in aging-related diseases. Chugai will then develop antibody-based drugs based on the findings.
July 7, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
PharmaEssentia USA Announces Appointment of Jeffrey Williams as Independent Director
December 25, 2025
·
2 min read
Press Releases
Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market
November 27, 2025
·
3 min read
Patents
Proliferating Patents, Lawsuits Stave Off Pharmas’ Generic Competitors
An analysis finds that pharmas frequently file multiple similar patents on drugs, then use them as the basis for questionable litigation against would-be competitors.
February 18, 2026
·
4 min read
·
Shawna Williams
Press Releases
Clongen Laboratories, LLC Announces Launch of Sister Company Clongen Pharma, LLC in March 2026
August 26, 2025
·
2 min read
Editorial
GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling
After Emma Walmsley steps down as GSK CEO in January, Vertex Pharma’s Reshma Kewalramani will be the sole female CEO at a top-20 pharma company. Still, there are many prominent women in pharma that could someday break through again.
September 29, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Press Releases
Sonic Healthcare USA, Inc. Announces Acquisition of Cairo Diagnostics LLC to Expand Sonic’s National Hematology Oncology Testing Capabilities
August 24, 2025
·
4 min read
Press Releases
PharmaEssentia USA Announces Appointment of Dr. Barry Flannelly as Independent Director
November 10, 2025
·
2 min read
1 of 41,468
Next
